BeOne Medicines (ONC) Stock Forecast
Beigene
AI forecast: ONC
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Price over the last 6 months
ONC: score, valuation and dividends
AI-Stock Invest describes the company by published rules: its Smart Score against peers, valuation against the sector, dividend history checked across sources, and red flags. The same for every reader — information, not a forecast and not advice.
Open in AI-Stock Invest → ONC valuation vs sectorPremium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Forecast track record
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumAbout This Company
BeiGene, Ltd. is a commercial-stage biopharmaceutical company that specializes in the discovery, development, and commercialization of molecularly targeted and immuno-oncology therapies for the treatment of cancer. BeiGene serves patients worldwide.
